Progress and Prospects in Translating Nanobiotechnology in Medical Theranostics

(E-pub Ahead of Print)

Author(s): Amna Batool, Farid Menaa*, Barkat Ali Khan, Bushra Uzair, Bouzid Menaa.

Journal Name: Current Nanoscience

Become EABM
Become Reviewer


The pace at which nanotheranostic technology for human disease is evolving has accelerated exponentially over the past five years. Nanotechnology is committed to utilize the intrinsic properties of materials and structures at submicroscopic-scale measures. Indeed, there is generally a profound influence of reducing physical dimensions of particulates and devices on their physico-chemical characteristics, biological properties, and performance. The exploration of nature’s components to work effectively as nanoscaffolds or nanodevices represents a tremendous and growing interest in medicine for various applications (e.g., biosensing, tunable control and targeted drug release, tissue engineering). Several nanotheranostic approaches (i.e., diagnostic plus therapeutic using nanoscale) conferring unique features are constantly progressing and overcoming all the limitations of conventional medicines including specificity, efficacy, solubility, sensitivity, biodegradability, biocompatibility, stability, interactions at subcellular levels. This review laconically introduces two major aspects of nanotechnology as an innovative and challenging theranostic strategy or solution: (i) the most intriguing (bare and functionalized) nanomaterials with their respective advantages and drawbacks; (ii) the current and promising multifunctional “smart” nanodevices.

Keywords: Nanotechnology, Nanomedicine, Nanotheranostics, Nanoplatforms, Nanodevices, Nanomaterials, Nanostructures, Nanosystems, Translational Medicine, Innovation

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1573413715666191126093258
Price: $95